Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.
Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Res Treat. 1985; 5(3):269-76.